Breadcrumb

RESP  |  Translational Research in Respiratory Diseases Program

RESP Program News

We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.

Rifampin for Latent TB: Shorter and safer than the standard treatment, but also cheaper

A new study shows that rifampin regimen is cheaper than isoniazid for latent tuberculosis

Why do some non-smokers get COPD while many heavy smokers don’t?

A new study highlights a strong risk factor for COPD related to lung development

Results of MI4 Emergency COVID-19 Research Funding (Round 2)

RI-MUHC researchers awarded MUHC Foundation funding for a second round of projects with potential impact in a short timeframe

We Care About Rare!

Researchers, advocates and patients gather on Rare Disease Research Day at the RI-MUHC

Results of MI4 Emergency COVID-19 Research Funding (Round 1)

RI-MUHC researchers awarded MUHC Foundation funding for projects with potential impact in a short timeframe

FRQ to create a province-wide COVID-19 Biobank

RI-MUHC researchers take leading roles in the initiative

The Pfizer Investigator Training Program comes to the RI-MUHC!

Clinical research educational training program benefits researchers, staff and students at the inaugural event

Rare respiratory diseases: Combining immunology and respiratory expertise for children and adults

The RI-MUHC is one of eight research centres participating in an NIH-funded project to accelerate the understanding of rare suppurative respiratory diseases...

Pulling out all the stops at the RI-MUHC’s first Open House for prospective trainees

World-renowned researchers. Vibrant learning environment. First-class facilities. If it sounds too good to be true, you weren’t at...

Explore news and events at the RI-MUHC